J&J talc unit asks judge to halt cancer lawsuits as it pursues $8.9
billion settlement
Send a link to a friend
[April 19, 2023]
By Dietrich Knauth
(Reuters) -A Johnson & Johnson subsidiary is again asking a U.S. judge
to pause tens of thousands of lawsuits alleging the company's baby
powder and other talc products cause cancer, as it seeks to resolve the
litigation in bankruptcy after a federal appeals court found its first
attempt improper.
At a Tuesday hearing in Trenton, New Jersey, a lawyer for LTL Management
argued the lawsuits, which are already stayed against LTL, should also
be stopped against J&J, which has a market value of over $430 billion
and has not filed for bankruptcy itself.
LTL has said litigation against J&J would imperil its effort to
negotiate a comprehensive settlement of all current and future talc
claims in its bankruptcy.
Two groups of cancer plaintiffs and the U.S. Department of Justice's
bankruptcy watchdog have opposed the company's bid for a stay, arguing
it is a fraudulent attempt to evade the earlier court ruling and that
the second bankruptcy has "slim to nonexistent prospects" of success.
LTL attorney Greg Gordon pushed back on those arguments at the start of
the hearing, saying "the likelihood of a successful reorganization is
very high."
LTL believes it now has support of 70,000 to 80,000 claimants, enough to
meet the 75% voting threshold required for a bankruptcy court to approve
the settlement and make it binding on all claimants, Gordon said.
Michael Winograd, an attorney representing talc claimants, said J&J does
not have support from a single claimant, only agreements with lawyers
who would recommend the deal to their clients.
J&J has exaggerated the level of support for the settlement to distract
from the fact that LTL's bankruptcy strategy had already been ruled
illegal, he added.
"Like anyone trying to pull off a magic trick, you have to have a
diversion," Winograd said.
More than 38,0000 talc lawsuits have been on hold since LTL first filed
for bankruptcy in 2021. Plaintiffs argue they should be allowed to
proceed with their lawsuits that allege the talc products caused various
forms of cancer after a federal appeals court nixed the company's
attempt to offload the litigation in bankruptcy.
[to top of second column]
|
A bottle of Johnson and Johnson Baby
Powder is seen in a photo illustration taken in New York, February
24, 2016. REUTERS/Mike Segar/Illustration/File Photo
The Philadelphia-based 3rd U.S.
Circuit Court of Appeals in January ruled LTL was not eligible for
bankruptcy because it was not in "financial distress."
Before the talc lawsuits could resume, LTL filed for bankruptcy a
second time, re-opening the legal battle over the bankruptcy's
legitimacy.
It has said its second bankruptcy is different because it has less
funding available and more plaintiff support for a settlement.
J&J has offered $8.9 billion to settle the claims, including $6.5
billion for ovarian cancer claims, $2 billion for mesothelioma
claims, and $400 million to settle consumer protection and false
marketing claims brought by state attorneys general. The company has
said its baby powder and other talc products are safe and do not
cause cancer.
The company on Tuesday reported overall sales of $24.7 billion for
the first quarter, but posted a net loss of $68 million due to a
one-time charge related to LTL's second bankruptcy filing.
J&J's effort to settle its talc liabilities in bankruptcy began in
October 2021. The company divided its consumer business in two and
offloaded the talc lawsuits onto its newly created subsidiary, LTL,
which almost immediately filed for Chapter 11 in an effort to halt
the litigation avalanche and force plaintiffs into a global
settlement.
U.S. Bankruptcy Judge Michael Kaplan agreed to protect J&J from
lawsuits during LTL's first bankruptcy, saying at the time it
offered the best way to fairly resolve all of the talc lawsuits
together.
Kaplan, who is also presiding over the second bankruptcy, said he
will rule on Thursday on LTL's request to stop the lawsuits again
and to give the company a second shot at a bankruptcy settlement.
(Reporting by Dietrich Knauth, Editing by Alexia Garamfalvi, Bill
Berkrot and Lincoln Feast)
[© 2023 Thomson Reuters. All rights
reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |